Canada · Delayed Price · Currency is CAD Sage Therapeutics Statistics
Total Valuation
TSXV:AAZ has a market cap or net worth of CAD 9.08 million. The enterprise value is 8.01 million.
| Market Cap | 9.08M |
| Enterprise Value | 8.01M |
Important Dates
The next estimated earnings date is Monday, August 25, 2025.
| Earnings Date | Aug 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:AAZ has 453.92 million shares outstanding. The number of shares has increased by 28.19% in one year.
| Current Share Class | 453.92M |
| Shares Outstanding | 453.92M |
| Shares Change (YoY) | +28.19% |
| Shares Change (QoQ) | +12.76% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 7.13% |
| Float | 450.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.29 |
| P/TBV Ratio | 1.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.94 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.60 |
Financial Position
The company has a current ratio of 8.00
| Current Ratio | 8.00 |
| Quick Ratio | 4.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.95% and return on invested capital (ROIC) is -23.24%.
| Return on Equity (ROE) | -35.95% |
| Return on Assets (ROA) | -22.13% |
| Return on Invested Capital (ROIC) | -23.24% |
| Return on Capital Employed (ROCE) | -40.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.25 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 49.92 |
| Average Volume (20 Days) | 306,234 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -37,921 |
| Operating Income | -2.82M |
| Pretax Income | -2.72M |
| Net Income | -2.72M |
| EBITDA | n/a |
| EBIT | -2.82M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 1.07 million in cash and n/a in debt, giving a net cash position of 1.07 million or 0.00 per share.
| Cash & Cash Equivalents | 1.07M |
| Total Debt | n/a |
| Net Cash | 1.07M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 7.03M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.76M |
Cash Flow
In the last 12 months, operating cash flow was -3.04 million and capital expenditures -40,882, giving a free cash flow of -3.08 million.
| Operating Cash Flow | -3.04M |
| Capital Expenditures | -40,882 |
| Free Cash Flow | -3.08M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:AAZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.19% |
| Shareholder Yield | n/a |
| Earnings Yield | -29.99% |
| FCF Yield | -33.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 21, 2022. It was a reverse split with a ratio of 0.4.
| Last Split Date | Apr 21, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |